单位：[1]Department of Rheumatology, China-Japan Friendship Hospital,Beijing, China[2]Rheumatology Unit, Department of Medicine, Solna, KarolinskaInstitutet, Karolinska University Hospital[3]Department of Laboratory Medicine,Clinical Microbiology, Karolinska Institutet, Karolinska University Hospital,Huddinge, Stockholm, Sweden
第一作者单位：[1]Department of Rheumatology, China-Japan Friendship Hospital,Beijing, China
推荐引用方式(GB/T 7714)：
Lu X.,Tang Q.,Lindroos E.,et al.THE ANTIMICROBIAL PEPTIDE LL-37 AND TYPE I INTERFERON IN IDIOPATHIC INFLAMMATORY MYOPATHIES[J].ANNALS of the RHEUMATIC DISEASES.2016,75:736-736.doi:10.1136/annrheumdis-2016-eular.5559.
APA：
Lu, X.,Tang, Q.,Lindroos, E.,Lindh, M.,Agerberth, B....&Wick, C..(2016).THE ANTIMICROBIAL PEPTIDE LL-37 AND TYPE I INTERFERON IN IDIOPATHIC INFLAMMATORY MYOPATHIES.ANNALS of the RHEUMATIC DISEASES,75,
MLA：
Lu, X.,et al."THE ANTIMICROBIAL PEPTIDE LL-37 AND TYPE I INTERFERON IN IDIOPATHIC INFLAMMATORY MYOPATHIES".ANNALS of the RHEUMATIC DISEASES 75.(2016):736-736
医学